가족성 고콜레스테롤혈증을 동반한 급성 뇌경색 환자의 특징
Characteristics of Acute Cerebral Infarction in Patients with Familial Hypercholesterolemia
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: The patients with familial hypercholesterolemia (FH) suffer from early onset atherosclerotic vascular disease due to high level of cholesterol and subsequent vascular inflammation, especially in the form of coronary artery disease. We investigated the clinical characteristics of FH associated cerebral infarction and its possible mechanism. Methods: Between January 2014 and May 2017, acute cerebral infarction patients who admitted to Chung-Ang University Hospital were reviewed from stroke registry and the diagnosis of FH was made based on the Dutch Lipid Clinic Network Diagnostic Criteria for FH. We reviewed their initial laboratory and brain imaging information, prescribed medication and followed lipid profile after discharge. Stroke mechanism was determined based on Trial of ORG 10172 in Acute Stroke Treatment classification. Results: Among 1,401 acute cerebral infarction or transient ischemic attack patients, one probable and three possible FH stroke patients were detected. All the patients denied of previous coronary artery disease history and initial lipid panel revealed high levels of total cholesterol (378±75 mg/dL) and low-density lipoprotein-cholesterol (238±56 mg/dL). Stroke mechanisms were heterogeneous, including one atherosclerotic, two vertebral artery dissection cases and one coagulation disorder. All the patients were combined with noticeable degree of intracranial atherosclerosis and were maintained with statin treatment. Conclusions: This study illustrates diverse stroke mechanism among stroke patients with FH. Further research is required to disclose exact incidence of FH among stroke population and effective treatment strategy.
Abstract
Background: The patients with familial hypercholesterolemia (FH) suffer from early onset atherosclerotic vascular disease due to high level of cholesterol and subsequent vascular inflammation, especially in the form of coronary artery disease. We investigated the clinical characteristics of FH associated cerebral infarction and its possible mechanism. Methods: Between January 2014 and May 2017, acute cerebral infarction patients who admitted to Chung-Ang University Hospital were reviewed from stroke registry and the diagnosis of FH was made based on the Dutch Lipid Clinic Network Diagnostic Criteria for FH. We reviewed their initial laboratory and brain imaging information, prescribed medication and followed lipid profile after discharge. Stroke mechanism was determined based on Trial of ORG 10172 in Acute Stroke Treatment classification. Results: Among 1,401 acute cerebral infarction or transient ischemic attack patients, one probable and three possible FH stroke patients were detected. All the patients denied of previous coronary artery disease history and initial lipid panel revealed high levels of total cholesterol (378±75 mg/dL) and low-density lipoprotein-cholesterol (238±56 mg/dL). Stroke mechanisms were heterogeneous, including one atherosclerotic, two vertebral artery dissection cases and one coagulation disorder. All the patients were combined with noticeable degree of intracranial atherosclerosis and were maintained with statin treatment. Conclusions: This study illustrates diverse stroke mechanism among stroke patients with FH. Further research is required to disclose exact incidence of FH among stroke population and effective treatment strategy.
참고문헌 (11)
- 이찬주, "가족성 고콜레스테롤혈증의 스크린, 진단, 치료: 한국지질동맥경화학회 교육위원회 심포지엄", 지질·동맥경화학회지, 7(2), pp.122~154 (2018), 한국지질동맥경화학회[DOI]
- Lee SH, "Characteristics and vascular complications of familial hypercholesterolemia in Korea", J Atheroscler Thromb, 23, pp.532~538 (2016)
- Nordestgaard BG, "Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population : guidance for clinicians to prevent coronary heart disease : consensus statement of the European Atherosclerosis Society", Eur Heart J, 34, pp.3478~3490 (2013)[DOI]
- Adams HP Jr, "Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment", Stroke, 24, pp.35~41 (1993)
- Beheshti S, "Relationship of familial hypercholesterolemia and high low-density lipoprotein cholesterol to ischemic stroke", Circulation, 138, pp.578~589 (2018)
- Hovland A, "Risk of ischemic stroke and total cerebrovascular disease in familial hypercholesterolemia", Stroke, 50, pp.172~174 (2018)
- Barkas F, "Statins decrease the risk of stroke in individuals with heterozygous familial hypercholesterolemia : a systematic review and meta-analysis", Atherosclerosis, 243, pp.60~64 (2015)
- Huijgen R, "Increased coagulation factor VIII activity in patients with familial hypercholesterolemia", Blood, 118, pp.6990~6991 (2011)
- Oh J, "Target achievement with maximal statin-based lipid-lowering therapy in Korean patients with familial hypercholesterolemia : a study supported by the Korean Society of Lipid and Atherosclerosis", Clin Cardiol, 40, pp.1291~1296 (2017)
- Raal F, "Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin", kexin type 9serine protease in patients with heterozygous familial hypercholesterolemia : the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder(RUTHERFORD)randomized trial, 2012, pp.126, 2408~2417
- Shin DG, "Clinical features of familial hypercholesterolemia in Korea : Predictors of pathogenic mutations and coronary artery disease-a study supported by the Korean Society of Lipidology and Atherosclerosis", Atherosclerosis, 243, pp.53~58 (2015)